Advertisement

Commercial Yeast Extracts Mediated Green Synthesis of Silver Chloride Nanoparticles and their Anti-mycobacterial Activity

  • Anbarasu Sivaraj
  • Vanaja Kumar
  • Revathy Sunder
  • Krupakar Parthasarathy
  • Govindaraju KasiveluEmail author
Brief Communication
  • 14 Downloads

Abstract

Green synthesis of silver chloride nanoparticles (AgCl NPs) using commercial yeast extract has been carried out. The physico–chemical characterizations of AgCl NPs were carried out by UV–visible spectroscopy, XRD, FTIR, HR-SEM equipped with EDAX and TEM. In vitro efficacy of anti-mycobacterial properties of AgCl NPs were determined by agar well diffusion and Luciferase Reporter Phage (LRP) assay were used against Mycobacteriumsmegmatis (MC2155) and Mycobacteriumtuberculosis H37Rv respectively. This shows that the AgCl NPs have potential anti-myobacterial activity against Mycobacterium tuberculosis H37Rv.

Keywords

Yeast extract AgCl nanoparticles LRP Anti-mycobacterial activity 

Notes

Acknowledgements

We thank the management of Sathyabama Institute of Science and Technology, Chennai for its strong support in research activities.

References

  1. 1.
    C. Jacob, S. Suvanand, S.S. Kuldeep, D. Lucica, B. Draurio, M. Andrei, M. Chen, P. Yogan (2014). Bull. World Health Organ. 92, 459.CrossRefGoogle Scholar
  2. 2.
    WHO, Global tuberculosis report (2018), https://www.who.int/tb/publications/global_report/en/
  3. 3.
    J. Xie, S. Lee, X. Chen (2010). Adv. Drug Deliv. Rev. 62, 1064.CrossRefGoogle Scholar
  4. 4.
    W.H. De Jong, P.J.A. Borm (2008). Int. J. Nanomed. 3, 133.CrossRefGoogle Scholar
  5. 5.
    R. Ducan (2003). Nat. Rev. Drug Discov. 2, 347.CrossRefGoogle Scholar
  6. 6.
    W.H. De Jong, R.E. Geertsma and B. Roszek, Nanotechnology in medical applications. Possible risks for human health, Report 265001002/2005, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.Google Scholar
  7. 7.
    European Technology Platform on Nanomedicine, Vision paper and basis for a strategic research agenda for nanomedicine. (European Commission, Luxembourg, 2005). ISBN 92-894-6599-5Google Scholar
  8. 8.
    J.J. Castellano, S.M. Shafii, F. Ko, G. Donate, T.E. Wright, R.J. Mannari, W.G. Payne, D.J. Smith, M.C. Robson (2007). Int. Wound J. 4, 114.CrossRefGoogle Scholar
  9. 9.
    J.W. Richard, B.A. Spencer, L.F. McCoy, E. Carina, J. Washington, P. Edgar (2002). J. Burns Surg. Wound Care 1, 11.Google Scholar
  10. 10.
    C.H. Luo, V. Shanmugam, C.S. Yeh (2015). NPG Asia Mater. 7, 1.CrossRefGoogle Scholar
  11. 11.
    P. Mulvaney (1996). Langmuir 12, 788.CrossRefGoogle Scholar
  12. 12.
    N. Ahmad, S. Sharma, M.K. Alam, V.N. Singh, S.F. Shamsi, B.R. Mehta, A. Fatma (2010). Colloids Surf. B: Biointerf. 81, 81.CrossRefGoogle Scholar
  13. 13.
    V. Gopinath, S. Priyadarshini, N. Meera Priyadharsshini, K. Pandian, P. Velusamy (2013). Mater. Lett. 91, 227.Google Scholar
  14. 14.
    V. Gopinath, D. Mubarak Ali, S. Priyadarshini, N.M. Priyadharsshini, N. Thajuddin, P. Velusamy (2012). Colloids Surf. B. 96, 69.CrossRefGoogle Scholar
  15. 15.
    L. Wang, C. Hu, L. Shao (2017). Int. J. Nanomedicine 12, 1227.CrossRefGoogle Scholar
  16. 16.
    S. Mohanty, P. Jena, R. Mehta, R. Pati, B. Banerjee, S. Patil, A. Sonawane (2013). Antimicrob. Agents Chemother. 57, 3688.CrossRefGoogle Scholar
  17. 17.
    R. Singh, L.U. Nawale, M. Arkile, U.U. Shedbalkar, S.A. Wadhwani, D. Sarkar, B.A. Chopade (2015). Int. J. Antimicrob. Agents 46, 183.CrossRefGoogle Scholar
  18. 18.
    R.K. Jivan, M.M. Ramjan, S.K. Ambadas, M.S. Bhimrao (2014). J. Microbiol. Biotechnol. Res. 4, 14.Google Scholar
  19. 19.
    A. Banu, V. Rathod (2013). J. Nanomed. Biotherapeut. Discov. 3, 110.CrossRefGoogle Scholar
  20. 20.
    P. Agarwal, A. Mehta, S. Kachhwaha, S.L. Kothari (2013). Adv. Sci. Eng. Med. 5, 709.CrossRefGoogle Scholar
  21. 21.
    R. Singh, L. Nawale, M. Aarkile, S. Wadhwani, U. Shedbalkar, S. Chopade, D. Sarkar, B.A. Chopade (2016). Int. J. Nanomed. 11, 1889.CrossRefGoogle Scholar
  22. 22.
    N.P. Bheemanagouda, T.C. Taranath (2016). Int. J. Pharm. Bio. Sci. 7, 89.Google Scholar
  23. 23.
    Papitha N,Jayshree N, PrabuSeenivasan S,Kumar V (2013). Int. J. Pharm. Sci. Rev. Res. 20, 135.Google Scholar
  24. 24.
    National Workshop on LRP 2011 Department of Bacteriology, National Institute for Research in Tuberculosis (NIRT) Chennai IndiaGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Anbarasu Sivaraj
    • 1
  • Vanaja Kumar
    • 1
  • Revathy Sunder
    • 1
  • Krupakar Parthasarathy
    • 1
  • Govindaraju Kasivelu
    • 2
    Email author
  1. 1.Centre for Drug Discovery and DevelopmentSathyabama Institute of Science and TechnologyChennaiIndia
  2. 2.Centre for Ocean ResearchSathyabama Institute of Science and TechnologyChennaiIndia

Personalised recommendations